The urokinase plasminogen activator system in breast cancer invasion and metastasis.
about
Molecular functions of thyroid hormones and their clinical significance in liver-related diseasesNew Insight on the Role of Plasminogen Receptor in Cancer ProgressionCandidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitorsTargeting the Notch signaling pathway in cancer therapeuticsReview on molecular and chemopreventive potential of nimbolide in cancerFisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathwayAntrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathwaysInhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionmaPericellular proteolysis in cancerIn vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancerRECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma.Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer.High Expression of Urokinase-Type Plasminogen Activator Is Associated with Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast.Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue.Human adipose-derived stem cell adipogenesis induces paracrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro.Three are better than one: plasminogen receptors as cancer theranostic targets.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.MS/MS-based strategies for proteomic profiling of invasive cell structures.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.Antimetastatic Effect by Targeting CTC Cluster-Response.HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells.MMP1, MMP9, and COX2 expressions in promonocytes are induced by breast cancer cells and correlate with collagen degradation, transformation-like morphological changes in MCF-10A acini, and tumor aggressiveness.The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.A Multiscale Mathematical Model of Tumour Invasive Growth.Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling.Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.
P2860
Q21284820-E732ECCE-F9AB-4A5D-BE5E-438A352D857CQ26798032-D0FB9449-3096-4B1A-ACBC-252F286EF4B9Q26830522-87CA3A23-962F-4437-9860-BCD1C5DBBD49Q26863580-584F53CD-9428-4F98-B6E2-083102721450Q28082973-C607D7DD-9C5F-4865-B910-593C18E53DC9Q28386841-CCD86FCB-8765-4AA1-8FA0-29A508077172Q28543224-EA22E763-DBF9-4342-88F4-F3259DA0B401Q33664568-3149D1A3-79A4-4B03-A335-267E79BA05B9Q33888940-001F5DB5-F4D6-4F77-B54E-81715FC42A23Q34430691-CA77572A-C8F2-4E78-8CE8-747311E4DC4CQ34997475-D1DF952D-3A84-4995-A9F6-FEBAB7940105Q35130808-B75DAC73-DD42-4A7D-B72F-95CA185DD2C7Q35179582-5457BC3D-BF55-42C8-A85E-5C9ED975BA2EQ36087199-A6FA5FB5-BF9F-4F43-BF37-996DF5035353Q36336377-4E654E0E-0D39-4589-888B-30753C98D8A4Q37056598-AEE00297-797D-49B1-A234-5FF88990691CQ37056918-F97D4776-D995-4AD6-A4C2-FFA02303D3F9Q37075568-E48DCF9B-CAEE-4AA7-9062-E5E4A88B6454Q37231266-DCD31E67-B73B-4C1F-AF87-53D27DCA616AQ38099731-C77B91B5-E8EF-408B-9175-D578809A62BFQ38198582-9F6270AB-AB09-45E1-8B3D-CF466A4D8384Q38258895-78AB4653-CC91-4C76-99D1-D16379EA9778Q38423064-9B79F91D-5FAF-4DE2-8C0B-1B4FC9392A1AQ38790960-76A535BF-8B79-4D80-A315-8E33191B673FQ38942148-99C0EEDF-9909-432B-84BA-A3868DED89DEQ39030249-0D9B2AAF-52D7-4DF7-BEB0-EA2647BFF274Q39456396-BF474E4A-9FB8-4F37-849A-5C5478D413C9Q39722375-A20E1ABF-C32E-44A5-BC4B-25575FA60288Q39742389-4ABEFF08-829B-417C-B36B-1CAB170951C9Q41530419-EBAAA5E1-9047-4004-B0EE-B5B2E4EF3CF2Q41717944-89C903EA-8A5C-4A56-AC90-306980CE34CEQ42182045-480A79FA-8AD1-4C7B-94A4-7D067A557B8FQ42516196-BE931AD7-EB00-4A81-AAB1-1C766D5A47CDQ47098588-4E0FB9E1-6101-48A0-88D8-CF298245D11EQ47654322-DA241A1D-1F09-4698-9715-EE9A20CAF50EQ47968431-BB283E8D-C313-4376-81F0-8F376C3E105EQ49646730-0B8AB8A6-C2B9-434C-B2FD-F2285E07D79FQ50955643-26885CF5-6CCE-484C-B7C7-BA07B157B109Q53116632-312EA0FE-4E90-42FE-9C7C-B13A3F2D53F7Q53213608-7B68F046-0FD6-4D43-8CBB-20434834347C
P2860
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
@en
type
label
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
@en
prefLabel
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
@en
P1476
The urokinase plasminogen activator system in breast cancer invasion and metastasis.
@en
P2093
Linlin Tang
Xiuzhen Han
P304
P356
10.1016/J.BIOPHA.2012.10.003
P577
2012-11-15T00:00:00Z